(Q51130246)

30 March 2018

title

Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. (English)

1 reference

30 March 2018

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

3

1 reference

30 March 2018

author name string

Yen-Chun Lee

1

1 reference

30 March 2018

Jin-Shang Wu

2

1 reference

30 March 2018

Chin-Sung Chang

4

1 reference

30 March 2018

Feng-Hwa Lu

5

1 reference

30 March 2018

Chih-Jen Chang

6

1 reference

30 March 2018

publication date

3 July 2014

1 reference

30 March 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

30 March 2018

volume

49

1 reference

30 March 2018

issue

8

1 reference

30 March 2018

page(s)

1001-1006

1 reference

30 March 2018

Cholesterol gallstone disease.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gallbladder disease is associated with insulin resistance in a high risk Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Standards of medical care in diabetes--2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Hepatic insulin resistance directly promotes formation of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gender and metabolic differences of gallstone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Diet and gallstones in Italy: the cross-sectional MICOL results.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gallstones and diabetes: a case-control study in a free-living population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

A population study on the prevalence of gallstone disease: the Sirmione Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Metabolic syndrome as a risk factor for gallstone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Gallstone prevalence in Germany: the Ulm Gallbladder Stone Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.920912

10.3109/00365521.2014.920912

21 January 2018

Identifiers

DOI

1 reference

30 March 2018

1 reference

30 March 2018